Post-IPO Debt Pharmaceutical Companies

Trulieve is a pharmaceutical company that manufactures integrated seed-to-sale medical cannabis products for brain and health treatments.

Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc. (FBIO).

LSL Pharma Group is a manufacturing company that innovates and manufactures life sciences products.

Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.

Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs.

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

TGOD grows high quality, organic cannabis with sustainable, all-natural principles. TGOD has a funded capacity of 116,000 kg.

Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.

FLUENT utilizes capital and expertise in making strategic investments to help launch mature and professional cannabis markets.

Chalice Brands is a fast growing company and leading cannabis oil solutions company built around recognized brands.

Medexus Pharma is a rare disease pharmaceutical company focusing on therapeutic areas of rheumatology and auto-immune conditions.

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Rubicon Organics is at the forefront of advancements with the production of clean, craft-style, affordable, organic cannabis products.

Christina Lake Cannabis focuses on oil extraction that provides for more significant margin opportunities.

Tricida operates in the healthcare industry focusing on pharmaceutical business.